CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
-6.21%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$26.3M
AUM Growth
+$26.3M
(-24%)
Cap. Flow
-$17.9M
Cap. Flow
% of AUM
-67.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
3
Reduced
2
Closed
–
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
$266K |
| 2 |
Aclaris Therapeutics
ACRS
|
$133K |
| 3 |
Compass Therapeutics
CMPX
|
$85.3K |
| 4 |
ALLK
Allakos
ALLK
|
$71.7K |
| 5 |
ELEV
Elevation Oncology
ELEV
|
$58 |
Top Sells
| 1 |
MTEM
Molecular Templates, Inc.
MTEM
|
$12.1M |
| 2 |
Savara
SVRA
|
$6.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Savara
SVRA
$567M
| $12.5M | 47.59% | 3,313,602 -1,667,202 | -33% | -$6.3M |
|
2
Xeris Biopharma Holdings
XERS
$1.26B
| $10.5M | 39.87% | 5,641,920 | – | – |
|
3
Rezolute
RZLT
$619M
| $1.74M | 6.61% | 1,318,967 | – | – |
|
|
MTEM
4
DELISTED
Molecular Templates, Inc.
MTEM
| $865K | 3.29% | 136,866 -1,916,125 | -93% | -$12.1M |
|
|
5
Apogee Therapeutics
APGE
$2.17B
| $266K | 1.01% | +12,472 | New | +$266K |
|
|
6
Compass Therapeutics
CMPX
$483M
| $171K | 0.65% | 86,773 +43,307 | +100% | +$85.3K |
|
|
7
Aclaris Therapeutics
ACRS
$209M
| $133K | 0.51% | +19,473 | New | +$133K |
|
|
ALLK
8
DELISTED
Allakos
ALLK
| $112K | 0.43% | 49,329 +31,596 | +178% | +$71.7K |
|
|
ELEV
9
DELISTED
Elevation Oncology
ELEV
| $14.5K | 0.05% | 21,813 +88 | +0.4% | +$58 |
|